| Specialty Retail Industry | Consumer Discretionary Sector | Sebastian Serrell-Watts CEO | OTC PINK Exchange | 71639C103 CUSIP |
| US Country | 1 Employees | - Last Dividend | 12 Aug 2014 Last Split | - IPO Date |
Petlife Pharmaceuticals, Inc. is a company committed to the advancement of veterinary medicine, focusing on the development and sale of pharmaceuticals and nutraceuticals aimed at treating pet cancer and autoimmune diseases, such as arthritis. Based in Los Angeles, California, they are pioneering in their approach to pet health, especially in the realm of serious diseases afflicting pets across the United States. Their research and development efforts are primarily centered on Vitalzul, their flagship product, which targets the inhibition of blood vessel formation in solid tumors—an innovative approach to cancer treatment in pets.
This principal product by Petlife Pharmaceuticals is designed to combat pet cancer by inhibiting angiogenesis, the formation of new blood vessels, thereby preventing the growth and spread of solid tumors. Vitalzul is in the process of being developed not just as an oral medication that pet owners can easily administer, but also as a more potent, concentrated formula for intravenous and injectable use, meant for direct application to tumors by veterinary professionals.
Building on the foundation laid by Vitalzul, Petlife is expanding its portfolio to include prescription-strength oral pharmaceuticals. These are specifically designed for pets suffering from cancer and autoimmune diseases, offering a more accessible and non-invasive treatment option for pet owners and their beloved animals.
For more aggressive treatment approaches, Petlife is developing concentrated versions of Vitalzul intended for intravenous and injectable administration. This form of treatment is ideal for direct administration to tumors, offering a targeted approach to combating cancer in pets. This development represents a significant step forward in veterinary cancer treatment, providing more options for veterinarians and pet owners dealing with advanced cases.
Recognizing the importance of ease of use and the challenge of administering medication to pets, Petlife is also innovating in the area of pet nutrition by developing edible treats for dogs and cats. These treats are not only palatable but are also designed to deliver health benefits, supporting the overall well-being of pets and potentially easing the symptoms of diseases like cancer and arthritis.